Microbial Identification Methods Global Market Report 2025
상품코드:1825815
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
미생물 동정법 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 연평균 성장률(CAGR) 7.2%로 72억 5,000만 달러로 성장할 것입니다. 예측 기간의 성장은 신속한 미생물 검사에 대한 수요 증가, 미생물 연구 개발, 자동화 시스템 도입 확대, 가처분 소득 증가, 식품 안전에 대한 정부의 노력 증가 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 신제품 출시, 미생물 식별 기술 발전, 자동 세균 식별 시스템 채택, 미세유체 공학, 로봇 공학, 나노기술 발전, 전략적 파트너십 등이 있습니다.
향후 5년간 7.2%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 영국과 싱가포르에서 조달하는 차세대 염기서열 분석(NGS) 키트와(PCR) 기반 식별 패널의 비용을 증가시켜 전염병 대응 지연을 악화시키고 공중 보건 지출을 증가시켜 미국의 전염병 조사에 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
감염병 확산은 미생물 동정법 시장의 확대를 촉진할 것으로 예상됩니다. 감염성 질환은 바이러스, 세균, 곰팡이, 기생충 등 유해한 병원균이 체내에 침입하여 발생하는 질병입니다. 주요 감염질환으로는 HIV/AIDS(인간면역결핍바이러스/후천성면역결핍증후군), 결핵, 말라리아 등이 있습니다. 이러한 감염증이 유행하는 배경에는 항균제 내성, 기후변화, 인구 증가 등의 요인이 있습니다. 미생물 동정법은 감염증의 원인 병원체에 대한 중요한 정보를 제공함으로써 감염증의 진단, 치료, 예방에 중요한 역할을 하고 있습니다. 이는 의료 전문가가 환자 치료에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다. 예를 들어, 2023년 1월 캐나다 정부는 2022년 10월에 135건의 광견병 표본이 제출되었고, 2022년 11월에는 159건의 표본이 제출되었다고 보고했습니다. 또한, 미국 질병예방통제센터(CDC)는 미국 내 결핵 발병률이 5.9% 증가하여 2021년 7,874건에서 2022년 8,331건으로 증가할 것이라고 보고했습니다. 그 결과, 감염성 질환의 유병률 증가가 미생물 동정법 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 미생물 동정법 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 미생물 동정법 시장 : 성장률 분석
세계의 미생물 동정법 시장 실적 : 규모와 성장, 2019-2024
세계의 미생물 동정법 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 미생물 동정법 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 미생물 동정법 시장 : 방법별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
유전자형
표현형
단백질형
세계의 미생물 동정법 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세균 동정 시스템
미생물 계수 시스템
세균 내성 동정 시스템
미생물 분석기
기타 유형
세계의 미생물 동정법 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제약 및 바이오테크놀러지 기업
병원 및 진단 검사실
식품 검사 연구소
기타 최종사용자
세계의 미생물 동정법 시장 : 하위 세분화 유전자형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응(PCR)
16SrRNA 시퀀싱
DNA 마이크로어레이
차세대 시퀀싱(NGS)
전장 유전체 시퀀싱(WGS)
리보타이핑
FISH(Fluorescent In Situ Hybridization)
랜덤 증폭다형DNA(RAPD) 분석
세계의 미생물 동정법 시장 : 하위 세분화 표현형, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
문화에 기반한 방법
생화학 검사
현미경 검사
그람 염색
항생제 감수성 시험(AST)
성장 패턴 식별
콜로니 형태 특성 평가
세계의 미생물 동정법 시장 : 하위 세분화 단백질형, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
질량 분석(MALDI-TOF MS)
웨스턴 블롯팅
단백질 프로파일링
면역측정법(ELISA)
2차원 겔 전기영동
제7장 지역별·국가별 분석
세계의 미생물 동정법 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 미생물 동정법 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
미생물 동정법 시장 : 경쟁 구도
미생물 동정법 시장 : 기업 개요
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Sumitomo Corporation Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
GE Healthcare
Avantor Inc.
Eurofins Scientific SE
Lonza Group AG
Sartorius AG
Charles River Laboratories International Inc.
bioMerieux SA
Shimadzu Corporation
Waters Corporation
Bio-Rad Laboratories Inc.
Bruker Corporation
Qiagen N.V.
Beckman Coulter Inc.
HiMedia Laboratories
Hardy Diagnostics
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
미생물 동정법 시장 2029 : 새로운 기회를 제공하는 국가
미생물 동정법 시장 2029 : 새로운 기회를 제공하는 부문
미생물 동정법 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Microbial identification methods encompass systematic approaches and laboratory techniques utilized to ascertain the identity and characteristics of microorganisms through the analysis of their phenotypic (observable traits) and genotypic (genetic) properties. These methods play a pivotal role in diagnosing infectious diseases, ensuring food and water safety, exploring microbial ecology, and devising effective treatments or preventive measures against pathogenic microorganisms.
Within the microbial identification methods market, the primary categories include genotypic, phenotypic, and proteotypic methods. Genotypic techniques entail identifying microorganisms based on their genetic composition, such as DNA or RNA sequences. Various types of these methods include bacterial identification systems, microbial enumeration systems, bacterial resistance identification systems, microbiology analyzers, and other variants utilized across diverse end-user sectors, including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, food testing laboratories, and other entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The microbial identification methods market research report is one of a series of new reports from The Business Research Company that provides microbial identification methods market statistics, including microbial identification methods industry global market size, regional shares, competitors with a microbial identification methods market share, detailed microbial identification methods market segments, market trends, and opportunities, and any further data you may need to thrive in the microbial identification methods industry. This microbial identification methods research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microbial identification methods market size has grown strongly in recent years. It will grow from $5.09 billion in 2024 to $5.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to growth in the prevalence of infectious diseases, increased funding for research and development in diagnostics, increased focus on infection control measures in healthcare facilities, increased food safety concerns, and rising demand for microbial identification methods.
The microbial identification methods market size is expected to see strong growth in the next few years. It will grow to $7.25 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing demand for rapid microbiology testing, developments in microbial studies, growing adoption of automated systems, rising disposable incomes, and increasing government initiatives for food safety. Major trends in the forecast period include new product launches, advancements in microbial identification techniques, adoption of automated bacterial identification systems, advancements in microfluidics, robotics and nanotechnology, and strategic partnerships.
The forecast of 7.2% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. infectious disease research by driving up the cost of next-generation sequencing (NGS) kits and (PCR)-based identification panels sourced from the UK and Singapore, exacerbating delays in outbreak response and increasing public health spending. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of infectious diseases is expected to drive the expansion of the microbial identification methods market. Infectious diseases are illnesses caused by harmful pathogens, including viruses, bacteria, fungi, and parasites, that enter the body. Major infectious diseases include HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome), tuberculosis, malaria, and others. The rising prevalence of these diseases can be linked to factors such as antimicrobial resistance, climate change, and population growth. Microbial identification methods play a critical role in diagnosing, treating, and preventing infectious diseases by providing essential information about the pathogens responsible for infections. This helps healthcare professionals make informed decisions about patient care. For instance, in January 2023, the Government of Canada reported that 135 rabies samples were submitted in October 2022, and 159 were submitted in November 2022. Additionally, the Centers for Disease Control and Prevention (CDC) reported a 5.9% increase in tuberculosis (TB) cases in the U.S., rising from 7,874 cases in 2021 to 8,331 cases in 2022. As a result, the increasing prevalence of infectious diseases is driving the growth of the microbial identification methods market.
Key players in the microbial identification methods market are dedicated to developing innovative solutions, such as mycobacteria and fungi in vitro diagnostic (IVD) solutions, to bolster their market presence. Mycobacteria and fungi IVD solutions encompass a variety of products and technologies tailored to detect, identify, and characterize mycobacterial and fungal pathogens in clinical specimens. For instance, in April 2023, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, introduced the MALDI Biotyper IVD software, a novel mycobacteria and fungi IVD solution. This solution boasts enhanced accuracy and speed in microbial identification, leveraging MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) mass spectrometry technology. The platform enables rapid identification of mycobacteria and fungi from cultured samples within minutes, significantly reducing turnaround time compared to traditional methods. Moreover, the new solutions offer expanded databases and robust software algorithms for improved specificity and sensitivity, facilitating precise identification of a wider range of mycobacterial and fungal species.
In January 2023, Biolog Inc., a biotechnology company based in the United States, completed the acquisition of MIDI Labs and MIDI, Inc. for an undisclosed sum. Through this strategic acquisition, Biolog endeavors to bolster its capabilities in microbial identification and characterization by amalgamating MIDI's cutting-edge fatty acid methyl ester (FAME) analysis technology with its existing phenotype-based systems. This integration aims to create a more comprehensive suite of diagnostic tools. MIDI Labs, based in the US, is recognized as a pioneering force in microbial identification methods.
Major companies operating in the microbial identification methods market are Merck KGaA, Sumitomo Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, GE Healthcare, Avantor Inc., Eurofins Scientific SE, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., bioMerieux SA, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Beckman Coulter Inc., HiMedia Laboratories., Hardy Diagnostics., LuminUltra Technologies Ltd., Biolog Inc.
North America was the largest region in the microbial identification methods market in 2024. The regions covered in the microbial identification methods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the microbial identification methods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The microbial identification methods market consists of revenues earned by entities by providing services such as fatty acid analysis, biochemical testing, antimicrobial susceptibility testing (AST), and mass spectrometry (MS). The market value includes the value of related goods sold by the service provider or included within the service offering. The microbial identification method market also includes sales of microbial identification systems, mass spectrometry instruments, sequencing platforms, culture media and kits, and antimicrobial susceptibility testing (AST) systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microbial Identification Methods Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on microbial identification methods market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for microbial identification methods ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbial identification methods market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Method: Genotypic; Phenotypic; Proteotypic
2) By Type: Bacterial Identification System; Microbial Enumeration System; Bacterial Resistance Identification Systems; Microbiology Analyzer; Other Type
3) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Diagnostic Laboratories; Food Testing Laboratories; Other End-Users
Subsegments:
1) By Genotypic: Polymerase Chain Reaction (PCR); 16S rRNA Sequencing; DNA Microarrays; Next-Generation Sequencing (NGS); Whole Genome Sequencing (WGS); Ribotyping; Fluorescence In Situ Hybridization (FISH); Random Amplified Polymorphic DNA (RAPD) Analysis
3. Microbial Identification Methods Market Trends And Strategies
4. Microbial Identification Methods Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Microbial Identification Methods Growth Analysis And Strategic Analysis Framework
5.1. Global Microbial Identification Methods PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Microbial Identification Methods Market Growth Rate Analysis
5.4. Global Microbial Identification Methods Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Microbial Identification Methods Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Microbial Identification Methods Total Addressable Market (TAM)
6.1. Global Microbial Identification Methods Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genotypic
Phenotypic
Proteotypic
6.2. Global Microbial Identification Methods Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial Identification System
Microbial Enumeration System
Bacterial Resistance Identification Systems
Microbiology Analyzer
Other Type
6.3. Global Microbial Identification Methods Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Hospitals And Diagnostic Laboratories
Food Testing Laboratories
Other End-Users
6.4. Global Microbial Identification Methods Market, Sub-Segmentation Of Genotypic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
16S rRNA Sequencing
DNA Microarrays
Next-Generation Sequencing (NGS)
Whole Genome Sequencing (WGS)
Ribotyping
Fluorescence In Situ Hybridization (FISH)
Random Amplified Polymorphic DNA (RAPD) Analysis
6.5. Global Microbial Identification Methods Market, Sub-Segmentation Of Phenotypic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture-Based Methods
Biochemical Testing
Microscopic Examination
Gram Staining
Antibiotic Susceptibility Testing (AST)
Growth Pattern Identification
Colony Morphology Characterization
6.6. Global Microbial Identification Methods Market, Sub-Segmentation Of Proteotypic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass Spectrometry (MALDI-TOF MS)
Western Blotting
Protein Profiling
Immunoassays (ELISA)
Two-Dimensional Gel Electrophoresis
7. Microbial Identification Methods Market Regional And Country Analysis
7.1. Global Microbial Identification Methods Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Microbial Identification Methods Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
